TUESDAY, Nov. 25, 2025 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use with subsequent prepregnancy or early pregnancy discontinuation is...

Highlights: Glucagon-like peptide-1 receptor agonists reduce major cardiovascular events in type 2 diabetes R

Glucagon-like peptide-1 receptor agonists lower the risk of heart attack and stroke in type 2 diabetes.

Glucagon-like peptide-1 receptor agonists lower the risk of heart attack and stroke in type 2 diabetes.

GLP-1 (Glucagon-like Peptide-1) drugs such as bliraglutide, semaglutide, and dulaglutide/b are originated for type 2 diabetic treatments and they

Diabetic drugs (GLP-1 drugs - Glucagon-Like Peptide-1) may provide equal better protection for the kidneys and heart in military retirees with type...

Public interest in GLP‑1 receptor agonists has exploded in recent years. These medicines, known as GLP‑1 RAs, include drugs like semaglutide,...

(Reuters) – U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss drugs...

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging research suggests these...

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging research suggests these...